5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Unichem Laboratories Ltd.

•
unichemlabs.comBSE: 506690NSE: UNICHEMLAB
Market Cap₹ 3,784 Cr.
Current Price
High / Low₹ 687 / 278
Stock P/E12.4
Book Value₹ 391
Price to Book0.76
Dividend Yield0.00 %
ROCE10.7 %
ROE9.8 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Formulations: 91.6% • Bulk Drugs & Chemicals: 6.5% • Other Operating Revenues: 1.9%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 49.1% CAGR over last 5 years
  • Latest quarter profit grew 496.1% YoY, showing strong momentum
  • Operating margins have improved to 8.4% from -0.5%
  • Company comfortably covers its interest (10.3x coverage)
  • Company generates healthy free cash flow
  • Company maintains a comfortable, low leverage position

CONS

  • Company has a low return on capital employed of 4.9%
  • Company has a low return on equity of 3.9% over last 3 years
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.04x)
  • Recurring exceptional / one-off items are inflating headline profit
  • Effective tax rate is unusually low at 13.5% - earnings may be flattered

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.UNICHEMLAB537.4512.423783.960.0041.47496.08632.6220.1310.6811.06
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
423416466460483507533587527579521575633
395407435438443452448503504513476527599
Operating Profit2893122405586842266454833
OPM %6.62%2.11%6.68%4.71%8.31%10.94%16.04%14.25%4.27%11.43%8.59%8.29%5.28%
9679-119491497-372871116
Interest6765457578797
Depreciation29293231323231303231313130
Profit before Tax2-2273-1338276258-9-112931949
Tax %131.60%-11.93%-0.03%-2.57%73.50%9.21%6.47%8.36%-16.08%-9.89%9.93%41.94%15.35%
Net Profit000093305853-10-122641141
-0.09-3.4810.39-19.420.293.508.227.52-1.49-1.6937.541.555.89

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
6988151,1801,1041,2351,2701,3431,7852,1112,2022,308
7399461,2641,1551,1441,1971,3891,6981,8462,0182,116
Operating Profit-41-132-83-519173-4687265184192
OPM %-5.93%-16.19%-7.08%-4.60%7.38%5.73%-3.39%4.87%12.55%8.36%8.32%
66198915048-0-2635265277
Interest3888561723213232
Depreciation445167828491113123125125123
Profit before Tax-83-130-60-485122-176-85155292350
Tax %14.35%-2.58%57.34%-24.83%33.32%-50.49%-14.67%-10.36%11.04%13.52%13.02%
Net Profit-71-133-26-603433-202-94138253305
EPS11.94280.41-3.38-8.554.884.68-28.72-13.3219.5335.91—
Dividend Payout %25.09%1.38%-118.29%-46.80%82.05%85.18%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
5%
5 Years:
12%
3 Years:
18%

COMPOUNDED PROFIT GROWTH

10 Years:
9%
5 Years:
49%
3 Years:
—

STOCK PRICE CAGR

10 Years:
8%
5 Years:
14%
3 Years:
10%
1 Year:
9%

RETURN ON EQUITY

10 Years:
-1%
5 Years:
1%
3 Years:
4%
Last Year:
10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2022

Aug 1

₹ 2

Rs.4.0000 per share(200%)Final Dividend

2021

Jul 22

₹ 2

Rs.4.0000 per share(200%)Final Dividend

2018

Jul 19

₹ 2.50

Rs.5.0000 per share(250%)Dividend

2017

Jul 13

₹ 1.50

Rs.3.0000 per share(150%)Final Dividend

2016

Mar 17

₹ 1

Rs.2.0000 per share(100%)Interim Dividend

2020

Jun 19

₹ 2

Rs.4.0000 per share(200%)Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18141414141414141414
1,0442,6652,6022,5122,5352,5942,4092,4212,4312,697
118155204207120324284219427481
Trade Payables211226221250210183291351387357
13012991158233200185263284158
Total Liabilities1,5213,1903,1333,1423,1123,3143,1833,2683,5443,707
4875748068668809901,2571,2521,3001,213
Capital Work in Progress2502389233056749414712331100
149019265503922642100
282273339397538600625736989975
0000000642779829
Cash & Bank1668120123482114185158118295
472522768765651852967355328296
Total Assets1,5213,1903,1333,1423,1123,3143,1833,2683,5443,707

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
96-113-3162447-252-7314-74
Cash from Investing-1281,648-286-36-7410220350-241192
Cash from Financing59-881-2-62-121191-81-1061842
-0655-616-78-1623436-42-64198

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
70.2270.2270.2270.2270.2270.2270.2270.2270.22
0.890.941.050.980.981.000.991.000.90
11.5711.6511.6311.3210.9210.7510.7310.6310.46
Government0.000.000.000.000.000.000.000.000.00
17.3017.1817.1017.4817.8818.0318.0518.1518.42

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Updates

2026-09-11 - Unichem Laboratories Limited has informed the Exchange regarding 'Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018'.

2026-08-26
Spurt in Volume

2026-08-26 - Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Unichem Laboratories Limited has submitted their response.

2026-08-25
Spurt in Volume

2026-08-25 - Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-08-12
Shareholders meeting

2026-08-12 - Unichem Laboratories Limited has submitted the Exchange a copy Srutinizers report of undefined held on August 11, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-12
Copy of Newspaper Publication

2026-08-12 - Unichem Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026

2026-08-11
Shareholders meeting

2026-08-11 - Unichem Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 11, 2026

2026-08-11
Outcome of Board Meeting

2026-08-11 - Unichem Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-29
Action(s) initiated or orders passed

2026-07-29 - Unichem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

2026-07-14
Disclosure under SEBI Takeover Regulations

2026-07-14 - IPCA Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

News

Recent coverage and analyst commentary for UNICHEMLAB

Loading news…

🤖

AI Stock Analyst

Unichem Laboratories Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login